BioVendor Group

ProteoGenex is an established, innovative provider of biological specimens and clinical information of the highest quality standards.

We are a privately held US company founded in Los Angeles, CA in 2003. With headquarters in Culver City, CA, we also have a large, state-of-the-art research laboratory in Moscow, Russia.

The ProteoGenex team consists of 35 employees, including 30 Molecular Biologists, Cell Biologists, Biochemists, and Pathologists (15 PhDs, 5 MDs, 15 MSs).

Our biorepository offers an extensive inventory of biospecimens as well as an exclusive, custom-design human tissue-based research service, which is the company’s largest and fastest growing business segment.
Our unique and comprehensive biobank is composed of well-defined and categorized clinical samples, including frozen and FFPE tissues, blood, serum, plasma, bone marrow, tissue microarrays, etc. All ProteoGenex specimens are collected from a vast network of academic and professional clinical institutions under strict regulatory and ethical standards.

We have over 200,000 individual biomaterials covering disease targets in the fields of Oncology, Dermatology, Neurology, Immunology, Infectious Diseases, Autoimmune and Metabolic Disorders, and many more. Our products are derived from a variety of diseased human sources as well as from normal tissues. All specimens are supported by extensive pathology information and patient’s’ clinical history documentation.

AT CELLCARTA WE ARE DEDICATED TO WORKING WITH OUR PARTNERS TO FURTHER THE LIMITLESS POTENTIAL OF PRECISION MEDICINE

As a global contract research organization (CRO) laboratory, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials.

CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as sample logistics services.

At CellCarta we are experts at assessing the immune system, whether in the context of oncology, infectious diseases, or autoimmune diseases. With a proven track record in other therapeutic areas as, such as neurological and metabolic disorders, we handle all human biological specimens and deploy relevant technologies to extract valuable information for research and diagnostic applications. We provide assay development and testing services to support a wide variety of translational research, clinical trials, and diagnostic applications.

Committed to delivering the highest quality science and innovation, CellCarta recently acquired Clinical Logistics to expand its specialty specimen logistics and kitting services and Mosaic Laboratories for multiplex immunohistochemistry assays development and deployment.

Reflecting our commitment to quality, our sites hold the appropriate accreditations to support your regulatory requirements, inNeo-Epitope Discoverycluding CAP, CLIA, ISO15189 and ISO13485.

CellCarta is privately held and majority-owned by Arsenal Capital Partners.

Alpha Laboratories is a family-run laboratory and diagnostic supplies business based in Eastleigh, Hampshire, UK and celebrated its 40th anniversary in 2015.

Since 1975 we have helped scientists to improve the health of the nation by sourcing and supplying specialist products from leading worldwide manufacturers.

In addition the company has developed its own brand lines of essential laboratory consumables such as the high quality Pastette® transfer pipettes, eco friendly Fastrak® pipette tips and SpeciSafe® UN3373 compliant sample packaging.

Our wide range of liquid handling pipettes, sample tubes, microtubes, microplates, PCR and general lab consumables, plus molecular biology equipment, ensure top performance in the laboratory.

Alpha Laboratories supports clinical laboratories with an extensive array of diagnostic assays, reagents and equipment. These cover blood grouping, gastroenterology, clinical chemistry, haematology, haemostasis and immunology testing, plus consumables for sample collection and transport .

We are highly experienced in faecal calprotectin testing to distinguish between IBD and IBS. We also provide Faecal Occult Blood testing materials to Bowel Cancer Screening Programmes nationwide and are involved in the transition to the use of more specific and sensitive Faecal Immunochemical Tests (FIT). Alpha Laboratories is also promoting the use of specialist assays such as new Rapid Pathogen ID technology that could vastly improve the speed of targeted treatment for sepsis.

We are a customer focused company dedicated to providing exceptional service, support and value for money for medical and laboratory professionals.

We are proud to present the Biomex Network. Within the network, we are able to provide all necessary products and services that are needed to develop, validate, register and produce an IvD.
Biomex, founded in 1989, has over 25 years of experience in the delivery of human-based raw materials such as disease state plasma and patient samples. Over 95% of all delivered human materials are sourced in our donor centers in Heidelberg, Munich and Cameroon. In addition to the delivery of biological and clinical materials, Biomex also offers a spectrum of services, for example, assay validation or CE marking.

Medical Research Networx (MRN), our American affiliate, has an extensive network of Principal Investigators who perform biological sample collections of a broad range of patient popula- tions, including but not limited to infectious diseases, oncological, endocrinology, chronic diseases and normal. MRN’s network is capable of recruiting PI’s and providing administrative and regulatory assistance to develop protocol approved, client directed collections of any clinical population that are required from clients.

Biomex US is specialized in the production and delivery of an entire range of human serum from normal to flash frozen to AB male serum.

DiaMex, develops and produces plasma based manufacturer-independent multi-analyte serological controls. Aside from its own Optitrol portfolio, DiaMex also offers a wide range of tailor made serological controls.

ESfEQA, is an worldwide EQA program provider. Through the Biomex network, ESfEQA has the ability to supply an EQA scheme with samples that are most similar to patient samples.

Products
• Bulk plasma for production
• Residual patient samples
• Prospective sample collections
• Panels for R&D and QC
• Reagents for ELISA

We are proud to have a world-wide reach and to be the only company that covers all aspects of products and services needed for the R&D, QC and production of serological and NAT tests.

Cellworks is a world leader in Precision Medicine. We help physicians and payers navigate to the most efficacious, cost-effective treatments for patients in a transparent and timely manner. Cellworks’ key therapeutic areas are Oncology, Immunology, Dermatology and Infectious Diseases. Cellworks’ unique bio-simulation platform is a unified representation of biological knowledge, curated from heterogeneous datasets, applied to finding cure. Since 2005, backed by Artiman Ventures and Sequoia Capital, Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers, and internet software technologists working towards a common goal – attacking serious diseases to improve the lives of patients.